Metraipolis › archive › dc_fc6e454cc980

Efgartigimod for generalized myasthenia gravis in the extreme elderly (≥80 years): a multicenter retrospective real-world study — Europe PMC PMID:41280898

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41280898
DOI: 10.3389/fimmu.2025.1685233
License (as archived): solo-consultazione
Archived: 2026-11-08T18:27:22.227Z
SHA-256 of the archived text: 18b1726ce1ddc4a39a903616ba71535045dabca718c1b50183dcb76ada2478b0
Stable URL of this page: https://metraipolis.com/documento/dc_fc6e454cc980

How to cite

Efgartigimod for generalized myasthenia gravis in the extreme elderly (≥80 years): a multicenter retrospective real-world study — Europe PMC PMID:41280898 — Europe PMC (en), https://europepmc.org/article/MED/41280898 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc6e454cc980 (Metraipolis archive dc_fc6e454cc980, sha256 18b1726ce1ddc4a39a903616ba71535045dabca718c1b50183dcb76ada2478b0)

BibTeX

@misc{dcfc6e454cc980,
  title = {Efgartigimod for generalized myasthenia gravis in the extreme elderly (≥80 years): a multicenter retrospective real-world study — Europe PMC PMID:41280898},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41280898},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc6e454cc980; sha256 18b1726ce1ddc4a39a903616ba71535045dabca718c1b50183dcb76ada2478b0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41280898. Agents can read the archived copy with the MCP tool read_document.